<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Rigel Pharmaceuticals Inc. | Company News & Executive Profiles - RIGL | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Rigel Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Rigel Pharma: The Importance of Knowing Your Stock]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152018-rigel-pharma-the-importance-of-knowing-your-stock%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Stone Fox Capital submits: Last Thursday night, Rigel Pharma RIGL released disappointing results on its TASKi3 Phase 2b study on Rheumatoid Arthritis RA. The results showed that the placebo worked basically as well as the R788 pill. Now here is where you need to understand the stock and what was...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 29 Jul 2009 12:51:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/stone+fox+capital.html"><![CDATA[Stone Fox Capital]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">RIGL</category>
	</item>
	<item>
		<title><![CDATA[Rigel Pharmaceuticals: A Game Changer in the Works?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145726-rigel-pharmaceuticals-a-game-changer-in-the-works%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dr. Anthony submits: With the impending announcement of the Phase IIb data for Rigel's RIGL lead compound R-788, I thought I would share my analysis. Rheumatoid Arthritis is a chronic debilitating disease that requires life-long treatment, which makes it a lucrative market but also at the same time very competitive....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 28 Jun 2009 01:31:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/dr.+anthony.html"><![CDATA[Dr. Anthony]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">RIGL</category>
	</item>
	<item>
		<title><![CDATA[Rigel and Seattle Genetics: The Delicate Art of Expectation Management]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F119415-rigel-and-seattle-genetics-the-delicate-art-of-expectation-management%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: In my previous article, I discussed the pharmaceutical industry&#8217;s race after approved drugs and late stage agents with proof of concept in humans. I mentioned Rigel&#8217;s RIGL lead drug, R788, as a likely target for collaboration due to its impressive activity, the huge addressable market and the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Feb 2009 12:29:47 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">RIGL,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Rigel Still on Track, And Has Pfizer Found Its Next Blockbuster?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F113805-rigel-still-on-track-and-has-pfizer-found-its-next-blockbuster%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: In the pharmaceutical industry, 2008 will probably be marked by the big pharmas&#8217; insatiable appetite for new drugs. Threatened by fierce generic competition, the pharmaceutical giants were not only eager to pay generous acquisition premiums for marketed products, but were also willing to pay a lot of...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 08 Jan 2009 03:16:44 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">PFE,RIGL</category>
	</item>
	<item>
		<title><![CDATA[Rigel's Punishment May Prove Short-Sighted]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F103172-rigel-s-punishment-may-prove-short-sighted%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: Rigel Pharmceuticals' RIGL shares have lost almost half their value this week since the release of fresh data from a phase II study of its lead product, R788 in rheumatoid arthritis, which considering the new information was neither overwhelmingly negative, nor entirely new, seems an overly severe...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 31 Oct 2008 12:14:04 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/rigel.html"><![CDATA[Rigel]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">RIGL</category>
	</item>
	<item>
		<title><![CDATA[My Model Biotech Picks: What's Hot and What's Not]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90661-my-model-biotech-picks-what-s-hot-and-what-s-not%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[A. Reza Saadat submits:  Analyzing the performance of my previous picks is by far my favorite part of writing this blog. It has on many occasions allowed be to learn from my mistakes.I have moved the numbers to Google docs so that they are easier to read. Here is...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 13 Aug 2008 12:36:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/alnylam+pharmaceuticals+inc..html"><![CDATA[Alnylam Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">ALNY,AMGN,AMLN,CELG,RIGL,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Wednesday Options Update: CHK, MER, RIGL, MYL, HRS, IR, LIZ]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89465-wednesday-options-update-chk-mer-rigl-myl-hrs-ir-liz%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Rebecca Engmann Darst contributed to this report. Chesapeake Energy CHK &#8211; Highly intriguing call-spread activity to report this morning out of oil and natural gas extractor Chesapeake Energy, whose shares rose 2% to $45.79 following mixed oil inventory data. Chesapeake shares are more than $23 off their high of July...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 Aug 2008 09:38:06 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/chesapeake+energy+corp..html"><![CDATA[Chesapeake Energy Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/harris+corp..html"><![CDATA[Harris Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/ingersoll-rand.html"><![CDATA[Ingersoll-Rand]]></category>
		<category domain="http://resources.bnet.com/topic/liz+claiborne+inc..html"><![CDATA[Liz Claiborne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+inc..html"><![CDATA[Mylan Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HRS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LIZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">CHK,HRS,IR,LIZ,MER,MYL,RIGL</category>
	</item>
	<item>
		<title><![CDATA[Speak with other shareholders about: (OTC: HNSO), (NASDAQ: PARL), (AMEX: MCU) and (NASDAQ: RIGL) .]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200704/ai_n19533161]]></link>
		<description><![CDATA[M2 PRESSWIRE-12 April 2007-Stockwire.com: Speak with other  shareholders about: (OTC: HNSO), (NASDAQ: PARL), (AMEX: MCU) and  (NASDAQ: RIGL) .C1994-2007 M2 COMMUNICATIONS LTD    RDATE:12042007    AUSTIN, TX: A very interesting indicator to look for is where the  money is flowing into. We have...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[compensation]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/portals.html"><![CDATA[Portals]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">NDAQ,RIGL</category>
	</item>
	<item>
		<title><![CDATA[Issues Thursdays Stocks to Watch: ORMP! April 12, 2007.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200704/ai_n19533260]]></link>
		<description><![CDATA[M2 PRESSWIRE-12 April 2007-Wall Street Capital Funding LLC: Issues  Thursdays Stocks to Watch: ORMP! April 12, 2007C1994-2007 M2  COMMUNICATIONS LTD    RDATE:12042007    Weston, FLA. - Wall Street News Alert's "stocks to  watch" this morning are: Oramed Pharmaceuticals Incorporated  (OTCBB: ORMP), Healthnostics,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="tickers">NDAQ,RIGL</category>
	</item>
</channel>
</rss>
